Exhibit 99.1

Contact:		Jake Elguicze
		Treasurer and
		Vice President of Investor Relations
		610-948-2836

FOR IMMEDIATE RELEASE		October 25, 2011

TELEFLEX REPORTS THIRD QUARTER 2011 RESULTS

Revenue of $371.9 million — up 7.8%; up 3.2% constant currency

Limerick, PA — Teleflex Incorporated (NYSE: TFX) today announced financial results for the third quarter and nine months ended September 25, 2011.

THREE MONTH RESULTS

Third quarter 2011 net revenues were $371.9 million, an increase of 7.8% over the prior year period. Excluding the impact of foreign exchange, third quarter 2011 net revenues increased 3.2% over the prior year period.

Third quarter 2011 GAAP diluted earnings per share from continuing operations was $0.82, an increase of 203.7% over the prior year period. During the third quarter of 2010, Teleflex recorded losses on the extinguishment of debt totaling $20.9 million, net of tax. Third quarter 2011 adjusted diluted earnings per share from continuing operations were $1.03, a increase of 4.0% over the prior year period. The increase in adjusted diluted earnings per share is related to an increase in sales volume, improved pricing, as well as a reduction in interest expense. This was somewhat offset by higher manufacturing, raw material and fuel-related costs, and the continued investment in sales, marketing and research and development activities.

“Despite operating within a challenging macro environment, our momentum continued to build during the third quarter of 2011,” said Benson Smith, Chairman, President and CEO. “Our team’s renewed focus led to revenue growth across nearly every region and product family. Improved sales volumes contributed to our top line growth, as did select price increases within the Asia Pacific and North American regions. In addition, during the third quarter, we were awarded 11 group purchasing organization contracts, and we introduced five new products to the marketplace, positioning the Company for sustainable and profitable future growth.”

Added Mr. Smith, “Our profitability during the quarter was favorably impacted by expanded gross and operating margins on a sequential basis, as well as a lower tax rate. Overall, we are continuing to make progress toward the achievement of our longer-term growth objectives.”

NINE MONTH RESULTS

Net revenues for the first nine months of 2011 were $1.1 billion, an increase of 6.7% over the prior year period. Excluding the impact of foreign exchange, net revenues for the first nine months of 2011 increased 3.4% over the prior year period.

GAAP diluted earnings per share from continuing operations for the first nine months of 2011 was $1.94, an increase of 3.7% over the prior year period. Adjusted diluted earnings per share from continuing operations for the first nine months of 2011 was $2.85, a decrease of 3.1% over the prior year period. The decline in adjusted diluted earnings per share is related to higher manufacturing, raw material and fuel-related freight costs, unfavorable product mix and the continued investment in sales, marketing and research and development expenses. This was somewhat offset by an increase in sales volume and reduced interest expense.

THIRD QUARTER NET REVENUE BY PRODUCT GROUP

Critical Care third quarter 2011 net revenues were $245.1 million, an increase of 8.5% over the prior year period on an as reported basis. Excluding the impact of foreign exchange, third quarter 2011 net revenues increased 3.6% over the prior year period. The increase in revenue was due to higher sales of vascular access, anesthesia and urology products.

Surgical Care third quarter 2011 net revenues were $66.0 million, an increase of 7.1% over the prior year period on an as reported basis. Excluding the impact of foreign exchange, third quarter 2011 net revenues increased 1.9% over the prior year period. The increase in revenue was due to higher sales of ligation products.

Cardiac Care third quarter 2011 net revenues were $18.1 million, an increase of 4.0% over the prior year period. Excluding the impact of foreign exchange, third quarter 2011 net revenues decreased 1.7% over the prior year period. The decrease in revenue was due to lower sales of intra-aortic balloon pumps, due to a slight slowdown in the purchase of capital equipment.

OEM and Development Services third quarter 2011 net revenues were $42.4 million, an increase of 7.3% over the prior year period on an as reported basis. Excluding the impact of foreign exchange, third quarter 2011 net revenues increased 5.6% over the prior year period. The increase in revenue was due to higher sales of specialty suture, catheter fabrication and orthopedic implant products.

		Three Months Ended								% Increase/ (Decrease)
		September 25,				September 26,				Constant				Foreign				Total
		2011				2010				Currency				Currency				Change
		(Dollars in millions)
Critical Care		$	245.1			$	226.0				3.6	%			4.9	%			8.5	%
Surgical Care			66.0				61.6				1.9	%			5.2	%			7.1	%
Cardiac Care			18.1				17.4				(1.7	%)			5.7	%			4.0	%
OEM			42.4				39.5				5.6	%			1.7	%			7.3	%
Other			0.3				0.5				(57.4	%)			17.4	%			(40.0	%)
Total		$	371.9			$	345.0				3.2	%			4.6	%			7.8	%

OTHER FINANCIAL HIGHLIGHTS AND KEY PERFORMANCE METRICS

Depreciation and amortization expense of intangible assets and deferred financing costs and debt discount for the first nine months of 2011 was $74.5 million compared to $68.5 million for the first nine months of 2010.

Cash and cash equivalents at September 25, 2011 were $371.7 million.

Net accounts receivable at September 25, 2011 were $277.3 million.

Net inventories at September 25, 2011 were $311.4 million.

Net debt obligations at September 25, 2011 were $683.0 million.

December 31, 2010 balance sheet amounts were not referenced above because businesses were either sold or reclassified to discontinued operations during 2011 and the Company does not find comparisons to the December 31, 2010 balance sheet amounts to be meaningful.

2011 OUTLOOK

The Company’s financial estimates for 2011 are as follows:

Revenue in the range of $1.51 billion to $1.53 billion. This compares to the Company’s prior expectation for full year 2011 revenue in the range of $1.44 billion to $1.47 billion. The revised revenue guidance is associated with foreign currency fluctuations and the translation of foreign revenues into U.S. dollars. In terms of constant currency revenue growth, the Company expects to be between 3.0% to 3.5% for full year 2011. This compares to the Company’s prior expectation of constant currency revenue growth between 2.5% to 3.5% for full year 2011.

Adjusted earnings per share in the range of $4.05 to $4.10. This compares to the Company’s prior expectation for full year 2011 adjusted earnings per share in the range of $4.05 to $4.25. The reduction in the high-end of the EPS guidance range is due to the Company’s nine month year-to-date performance, as well as the Company’s expectations for the fourth quarter.

Cash flow from continuing operations for the full year is expected to be in the range of $150 to $180 million. This compares to the Company’s prior expectation for full year 2011 cash flow from continuing operations in the range of $180 to $210 million. The revised cash flow from operations guidance is primarily related to higher than expected inventory levels associated with the Company’s previously announced efforts to focus on gaining additional market share and reducing the amount of time required to fulfill customer orders, as well as an increase in accounts receivable.

2011 OUTLOOK EARNINGS PER SHARE RECONCILIATION

		Low				High
Diluted earnings per share attributable to common shareholders		$	2.75			$	2.80
Special items, net of tax		$	0.45			$	0.45
Intangible amortization expense, net of tax		$	0.70			$	0.70
Amortization of debt discount on convertible notes, net of tax		$	0.15			$	0.15
Adjusted earnings per share		$	4.05			$	4.10

CONFERENCE CALL WEBCAST AND ADDITIONAL INFORMATION

As previously announced, Teleflex will comment on its financial results on a conference call to be held today at 8:00 a.m. (ET). The call will be available live and archived on the company’s website at www.teleflex.com and the accompanying presentation will be posted prior to the call. An audio replay will be available until October 30, 2011, 12:00pm (ET), by calling 888-286-8010 (U.S./Canada) or 617-801-6888 (International), Passcode: 62497743.

ADDITIONAL NOTES

Constant currency revenue and growth exclude the impact of translating the results of international subsidiaries at different currency exchange rates from period to period. Constant currency revenue and growth include activity of a purchased company beyond the initial twelve months after the date of acquisition.

Certain financial information is presented on a rounded basis, which may cause minor differences.

Product group results and commentary exclude the impact of discontinued operations, items included in restructuring and impairment charges, and losses and other charges set forth in the condensed consolidated statements of income.

NOTES ON NON-GAAP FINANCIAL MEASURES

This press release includes certain non-GAAP financial measures. These measures include (i) adjusted diluted earnings per share, which excludes the effect of charges associated with our restructuring programs and asset impairments, losses and other charges related to refinancing transactions, costs associated with severance payments and benefits to be provided to our former chief executive officer, intangible amortization expense and the amortization of debt discount on convertible notes; (ii) constant currency revenue and growth, which exclude the impact of translating the results of international subsidiaries at different currency exchange rates from period to period; and (iii) cash flow from operations, excluding the impact of the adoption of an amendment to Financial Accounting Standards Board Accounting Standards Codification topic 860, “Transfers and Servicing”. Consistent with past practice, adjusted diluted earnings per share has not been adjusted to exclude the benefit resulting from the forfeiture of equity awards. Management believes these measures are useful to investors because they eliminate items that do not reflect Teleflex’s day-to-day operations. In addition, management uses these financial measures for internal managerial purposes, when publicly providing guidance on possible future results, and to assist in our evaluation of period-to-period comparisons. These financial measures are presented in addition to results presented in accordance with GAAP and should not be relied upon as a substitute for GAAP financial measures. Tables reconciling these non-GAAP measures to the most directly comparable GAAP measures are set forth below.

RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS

		Three Months Ended				Three Months Ended
		September 25, 2011				September 26, 2010
		(Dollars in thousands, except per share)
Income and diluted earnings per share attributable to common		$	33,463			$	10,761
shareholders		$	0.82			$	0.27
Restructuring and impairment charges			—				1,141
Tax benefit			—				(380	)
Restructuring and impairment charges, net of tax			—				761
			—			$	0.02
Losses and other charges (A)			—				32,742
Tax benefit			—				(11,866	)
Losses and other charges, net of tax			—				20,876
			—			$	0.52
Amortization of debt discount on convertible notes			2,455				1,536
Tax benefit			(892	)			(557	)
Amortization of debt discount on convertible notes, net of tax			1,563				979
		$	0.04			$	0.02
Intangible amortization expense			11,081				10,403
Tax benefit			(4,054	)			(3,794	)
Intangible amortization expense, net of tax			7,027				6,609
		$	0.17			$	0.16
Adjusted income and diluted earnings per share		$	42,053			$	39,986
		$	1.03			$	0.99

RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS

		Nine Months Ended				Nine Months Ended
		September 25, 2011				September 26, 2010
		(Dollars in thousands, except per share)
Income and diluted earnings per share attributable to common		$	79,018			$	75,425
shareholders		$	1.94			$	1.87
Restructuring and impairment charges			710				1,679
Tax benefit			(250	)			(652	)
Restructuring and impairment charges, net of tax			460				1,027
		$	0.01			$	0.03
Losses and other charges (A)			20,913				32,742
Tax benefit			(7,601	)			(11,866	)
Losses and other charges, net of tax			13,312				20,876
		$	0.33			$	0.52
Amortization of debt discount on convertible notes			7,212				1,536
Tax benefit			(2,621	)			(557	)
Amortization of debt discount on convertible notes, net of tax			4,591				979
		$	0.11			$	0.02
Intangible amortization expense			33,196				31,788
Tax benefit			(12,117	)			(11,538	)
Intangible amortization expense, net of tax			21,079				20,250
		$	0.52			$	0.50
Tax adjustments (B)			(2,165	)			—
		$	(0.05	)			—
Adjusted income and diluted earnings per share		$	116,295			$	118,557
		$	2.85			$	2.94

RECONCILIATION OF CASH FLOW FROM OPERATIONS

		Nine Months Ended				Nine Months Ended
		September 25, 2011				September 26, 2010
		(Dollars in thousands)
Cash flow from operations as reported		$	64,693			$	103,873
Add: Impact of the adoption of the amendment to Accounting Standards Codification topic 860 “Transfers and Servicing”			—				39,700
Less: Tax refund on sale of ATI business			—				59,499
Adjusted cash flow from operations		$	64,693			$	84,074

RECONCILIATION OF NET DEBT OBLIGATIONS

		September 25, 2011				December 31, 2010
		(Dollars in thousands)
Note payable and current portion of long-term borrowings		$	29,700			$	103,711
Long term borrowings			952,322				813,409
Unamortized debt discount			72,678				79,891
Total debt obligations			1,054,700				997,011
Less: cash and cash equivalents			371,699				208,452
Net debt obligations		$	683,001			$	788,559

ABOUT TELEFLEX INCORPORATED

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,600 people worldwide and serves healthcare providers in more than 130 countries. For additional information about Teleflex please refer to www.teleflex.com.

CAUTION CONCERNING FORWARD-LOOKING INFORMATION

This press release contains forward-looking statements, including, but not limited to, statements relating to forecasted 2011 total revenue, adjusted earnings per share and cash flow from continuing operations. Actual results could differ materially from those in the forward-looking statements due to, among other things, conditions in the end markets we serve, customer reaction to new products and programs, our ability to achieve sales growth, price increases or cost reductions; changes in the reimbursement practices of third party payors; our ability to realize efficiencies and to execute on our strategic initiatives; changes in material costs and surcharges; market acceptance and unanticipated difficulties in connection with the introduction of new products and product line extensions; product recalls; unanticipated difficulties in connection with the consolidation of manufacturing and administrative functions; unanticipated difficulties, expenditures and delays in complying with government regulations applicable to our businesses; the impact of government healthcare reform legislation; our ability to meet our debt obligations; changes in general and international economic conditions; and other factors described or incorporated in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K and the disclosure incorporated into Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended June 26, 2011.

TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

		Three Months Ended
		September 25,				September 26,
		2011				2010
		(Dollars and shares in thousands,
		except per share)
Net revenues		$	371,891			$	345,041
Cost of goods sold			193,617				178,477
Gross profit			178,274				166,564
Selling, general and administrative expenses			102,911				101,542
Research and development expenses			12,325				10,571
Net gain on sales of businesses and assets			—				(183	)
Restructuring and other impairment charges			(173	)			1,141
Income from continuing operations before interest, loss on extinguishments of debt and taxes			63,211				53,493
Interest expense			19,177				20,047
Interest income			(318	)			(219	)
Loss on extinguishments of debt			—				30,354
Income from continuing operations before taxes			44,352				3,311
Taxes (benefit) on income from continuing operations			10,600				(7,676	)
Income from continuing operations			33,752				10,987
Operating income from discontinued operations (including loss on disposal of $4 in 2011)			13,282				14,143
Taxes on income from discontinued operations			2,969				2,595
Income from discontinued operations			10,313				11,548
Net income			44,065				22,535
Less: Income from continuing operations attributable to noncontrolling interest			289				226
Income from discontinued operations attributable to noncontrolling interest			125				113
Net income attributable to common shareholders		$	43,651			$	22,196
Earnings per share available to common shareholders:
Basic:
Income from continuing operations		$	0.82			$	0.27
Income from discontinued operations		$	0.25			$	0.29
Net income		$	1.07			$	0.56
Diluted:
Income from continuing operations		$	0.82			$	0.27
Income from discontinued operations		$	0.25			$	0.28
Net income		$	1.07			$	0.55
Dividends per common share		$	0.34			$	0.34
Weighted average common shares outstanding:
Basic			40,684				39,933
Diluted			40,943				40,254
Amounts attributable to common shareholders:
Income from continuing operations, net of tax		$	33,463			$	10,761
Income from discontinued operations, net of tax			10,188				11,435
Net income		$	43,651			$	22,196

TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

		Nine Months Ended
		September 25,				September 26,
		2011				2010
		(Dollars and shares in thousands,
		except per share)
Net revenues		$	1,117,181			$	1,047,005
Cost of goods sold			590,371				535,329
Gross profit			526,810				511,676
Selling, general and administrative expenses			317,338				296,961
Research and development expenses			35,819				30,170
Net gain on sales of businesses and assets			—				(183	)
Restructuring and other impairment charges			3,598				1,679
Income from continuing operations before interest, loss on extinguishments of debt and taxes			170,055				183,049
Interest expense			51,108				58,501
Interest income			(676	)			(575	)
Loss on extinguishments of debt			15,413				30,354
Income from continuing operations before taxes			104,210				94,769
Taxes on income from continuing operations			24,422				18,687
Income from continuing operations			79,788				76,082
Operating income from discontinued operations (including gain on disposal of $52,265 in 2011 and $38,562 in 2010, respectively)			72,148				74,152
Taxes (benefit) on income from discontinued operations			(4,810	)			29,215
Income from discontinued operations			76,958				44,937
Net income			156,746				121,019
Less: Income from continuing operations attributable to noncontrolling interest			770				657
Income from discontinued operations attributable to noncontrolling interest			443				346
Net income attributable to common shareholders		$	155,533			$	120,016
Earnings per share available to common shareholders:
Basic:
Income from continuing operations		$	1.95			$	1.89
Income from discontinued operations		$	1.89			$	1.12
Net income		$	3.85			$	3.01
Diluted:
Income from continuing operations		$	1.94			$	1.87
Income from discontinued operations		$	1.88			$	1.11
Net income		$	3.82			$	2.98
Dividends per common share		$	1.02			$	1.02
Weighted average common shares outstanding:
Basic			40,426				39,879
Diluted			40,738				40,269
Amounts attributable to common shareholders:
Income from continuing operations, net of tax		$	79,018			$	75,425
Income from discontinued operations, net of tax			76,515				44,591
Net income		$	155,533			$	120,016

TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

		September 25,				December 31,
		2011				2010
		(Dollars in thousands)
ASSETS
Current assets
Cash and cash equivalents		$	371,699			$	208,452
Accounts receivable, net			277,340				294,196
Inventories, net			311,417				338,598
Prepaid expenses and other current assets			33,069				28,831
Prepaid taxes			41,527				3,888
Deferred tax assets			33,085				39,309
Assets held for sale			118,293				7,959
Total current assets			1,186,430				921,233
Property, plant and equipment, net			250,582				287,705
Goodwill			1,456,710				1,442,411
Intangible assets, net			897,846				918,522
Investments in affiliates			2,161				4,899
Deferred tax assets			340				358
Other assets			74,642				68,027
Total assets		$	3,868,711			$	3,643,155
LIABILITIES AND EQUITY
Current liabilities
Current borrowings		$	29,700			$	103,711
Accounts payable			76,245				84,846
Accrued expenses			112,575				117,488
Payroll and benefit-related liabilities			66,544				71,418
Derivative liabilities			15,330				15,634
Accrued interest			13,623				18,347
Income taxes payable			10,699				4,886
Deferred tax liabilities			5,725				4,433
Liabilities held for sale			53,531				—
Total current liabilities			383,972				420,763
Long-term borrowings			952,322				813,409
Deferred tax liabilities			383,557				370,819
Pension and postretirement benefit liabilities			110,501				141,769
Noncurrent liability for uncertain tax positions			63,949				62,602
Other liabilities			37,413				46,515
Total liabilities			1,931,714				1,855,877
Commitments and contingencies
Total common shareholders’ equity			1,932,151				1,783,376
Noncontrolling interest			4,846				3,902
Total equity			1,936,997				1,787,278
Total liabilities and equity		$	3,868,711			$	3,643,155

TELEFLEX INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

		Nine Months Ended
		September 25,
		2011				September 26, 2010
		(Dollars in thousands)
Cash Flows from Operating Activities of Continuing Operations:
Net income		$	156,746			$	121,019
Adjustments to reconcile net income to net cash provided by operating activities:
Income from discontinued operations			(76,958	)			(44,937	)
Depreciation expense			31,244				32,267
Amortization expense of intangible assets			33,196				31,789
Amortization expense of deferred financing costs and debt discount			10,064				4,425
Loss on extinguishments of debt			15,413				30,354
Gain on call options and warrants			—				(407	)
Debt modification costs			—				2,795
Stock-based compensation			2,469				6,946
Impairment of investments in affiliates			3,060				—
Net gain on sales of businesses and assets			—				(183	)
Deferred income taxes, net			(2,561	)			29,754
Other			(2,125	)			(27,099	)
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable			(41,260	)			(48,436	)
Inventories			(40,539	)			(17,544	)
Prepaid expenses and other current assets			(7,380	)			1,845
Accounts payable and accrued expenses			5,614				(22,149	)
Income taxes, net			(22,290	)			3,434
Net cash provided by operating activities from continuing operations			64,693				103,873
Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment			(27,561	)			(21,263	)
Proceeds from sales of businesses and assets, net of cash sold			100,905				75,943
Payments for businesses and intangibles acquired, net of cash acquired			(30,570	)			(82	)
Net cash provided by investing activities from continuing operations			42,774				54,598
Cash Flows from Financing Activities of Continuing Operations:
Proceeds from long-term borrowings			515,000				400,000
Repayment of long-term borrowings			(455,800	)			(460,770	)
Increase in notes payable and current borrowings			—				34,700
Proceeds from stock compensation plans			32,930				8,470
Payments to noncontrolling interest shareholders			—				(637	)
Dividends			(41,278	)			(40,704	)
Debt and equity issuance and amendment fees			(18,510	)			(48,041	)
Purchase of call options			—				(88,000	)
Proceeds from sale of warrants			—				59,400
Net cash provided by (used in) financing activities from continuing operations			32,342				(135,582	)
Cash Flows from Discontinued Operations:
Net cash provided by operating activities			25,446				42,223
Net cash used in investing activities			(1,744	)			(2,722	)
Net cash used in financing activities			—				(1,124	)
Net cash provided by discontinued operations			23,702				38,377
Effect of exchange rate changes on cash and cash equivalents			(264	)			(1,814	)
Net increase in cash and cash equivalents			163,247				59,452
Cash and cash equivalents at the beginning of the period			208,452				188,305
Cash and cash equivalents at the end of the period		$	371,699			$	247,757